Prognostic Value and Immune-Infiltration Pattern of KIF4A in Patients with Endometrial Carcinoma

Figure 3

Prognostic value of KIF4A in EC Patients. Kaplan-Meier survival analysis of (a) OS, (b) DSS, (c) PFI, and (d) ROC analysis for status (tumor or normal). Survival analysis of clinical subgroups, including (e) FIGO stage, (f) age, (g) histological type, (h) histologic grade, (i) venous invasion, and (j) BMI.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)